Stratatech Corp, a unit of Dublin, Ireland-based Mallinckrodt Plc, has received regulatory approval in the US for its treatment for thermal burns. The treatment, StrataGraft, is produced from two types of human skin cells, keratinocytes and dermal fibroblasts, which have been grown together to make a cellularised scaffold. It is a topical treatment, to be placed onto the burn by a healthcare provider.
